Latest Adverse effect Stories

FDA Participates in Global Efforts to Protect Consumers and Patients from Unsafe Drugs on the Internet

2011-09-29 12:31:00

SILVER SPRING, Md., Sept. 29, 2011 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration and other regulatory and international partners have completed the International Internet Week of Action (IIWA), a cooperative effort to curb online sales and distribution of counterfeit and illegal medical products. (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO) This year's IIWA, which ran between Sept. 20 and Sept. 27 is called OPERATION PANGEA IV, focused on websites supplying...

New Analysis Of The Cardiovascular Risks Of Common Non-Steroidal Anti-Inflammatory Drugs

2011-09-28 09:08:55

An updated study published in this week's PLoS Medicine gives some new information on the cardiovascular risks of non-steroidal anti-inflammatory drugs (NSAIDs) and suggests that among these commonly used drugs, naproxen and low dose ibuprofen are least likely to increase cardiovascular risk whereas diclofenac, even in doses available without prescription, elevates risk. Using only observational studies (30 case-control studies and 21 cohort studies) because randomised controlled trials...

Simmons Firm Investigates Type 2 Diabetes Drug Linked to Bladder Cancer

2011-09-21 14:15:00

Actos taken for a prolonged time period and at a high dosage has an increased risk of bladder cancer, FDA warns. Alton, IL (PRWEB) September 21, 2011 Simmons Browder Gianaris Angelides & Barnerd LLC is currently investigating claims that Actos, a drug manufactured by Takeda Pharmaceuticals to treat type 2 diabetes, can increase the risk of developing bladder cancer. Actos, FDA approved in 1999, is a drug that contains the active ingredient pioglitazone hydrochloride, a type of...

Qualitest Pharmaceuticals Issues a Nationwide Voluntary Recall of Oral Contraceptives

2011-09-15 15:05:00

HUNTSVILLE, Ala., Sept. 15, 2011 /PRNewswire/ -- Qualitest Pharmaceuticals today issued a voluntary, nationwide, retail-level recall of multiple lots of oral contraceptives. The recall is being implemented because of a packaging error, where select blisters were rotated 180 degrees within the card, reversing the weekly tablet orientation and making the lot number and expiry date no longer visible. This packaging error and the potential for this error to have affected other oral...

Notify FDA of Adverse Events with Medications and Medical Devices

2011-09-14 13:15:00

Ennis & Ennis, P.A. Recommends Patients Complete MedWatch Form to Notify FDA of Any Adverse Events Caused by Medications or Medical Devices (PRWEB) September 14, 2011 In a world of endless technology, there are so many unused informational resources for patients. According to Ennis & Ennis, P.A. one of the single most helpful resources for patients is the U.S. Food and Drug Administration (FDA) website. In addition to having the ability to research data on drugs and medical...

U.S. Public May Not Be Aware Of Important Uncertainties About Drug Benefits And Harms

2011-09-13 11:15:19

Explaining these uncertainties might improve their choices Many U.S. adults believe that only extremely effective drugs without serious adverse effects are approved, but providing explanations to patients highlighting uncertainties about drug benefits may affect their choices, according to a report in the September issue of Archives of Internal Medicine, one of the JAMA/Archives journals. The article is part of the journal's Less Is More series. Approval from the U.S. Food and Drug...

Pharmacists Need To Provide Better Information To Teenagers On Risks And Benefits Of Medicines

2011-09-05 11:48:02

A large proportion of teenagers regularly and frequently take some form of medication without receiving targeted information about the risks and benefits, according to a review of current research, to be presented at the annual congress of the International Pharmaceutical Federation (FIP) tomorrow (Tuesday). Dr Priya Bahri will tell delegates that 35% of boys and 45% of girls in Europe and the USA take painkillers for headaches every month. In addition, they take a variety of other...

Trauma Experts Criticize BBC's Holby City For 'Peddling Dangerous Drugs'

2011-09-02 12:12:57

Trauma experts have criticized the BBC over a recent episode of Holby City that effectively advertised and promoted a drug that has no proven record of saving lives According to Dr Ian Roberts, Head of the World Health Organization Collaborating Centre on Injury Control at the London School of Hygiene & Tropical Medicine, the recent episode ("Big Lies, Small Lies") seriously misrepresents the scientific evidence. "In clinical trials, Factor VIIa (the drug presented in the program)...

Shire Presents Positive Data from Fabry and Gaucher Disease Studies that Continue to Support Patient Switches to REPLAGALÂ® (agalsidase alfa) and VPRIVÂ® (velaglucerase alfa)

2011-08-31 09:09:00

NYON, Switzerland, Aug. 31, 2011 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, today announced positive data from several studies designed to evaluate the safety of switching to REPLAGAL (agalsidase alfa) from FabrazymeÂ® (agalsidase beta) and the long-term safety and benefits of switching to VPRIV (velaglucerase alfa) from CerezymeÂ® (imiglucerase). Study results are being presented at the 2011 Annual Symposium of the Society for...

Huge Worldwide Gaps In The Use Of Simple, Cheap And Proven Drugs For Secondary CVD Prevention

2011-08-29 20:27:55

There is great under-use of proven therapies for the secondary prevention of cardiovascular disease, according to results presented today from the PURE (Prospective Urban Rural Epidemiological) study. “The study indicates a large gap in secondary prevention globally," said Dr Salim Yusuf, lead author and Executive Director of the Population Health Research Institute at McMaster University, Canada. "We found extremely low rates of use of proven therapies in all countries, but these were...